Pennsylvania's State Board of Medicine sued Character.AI on May 1, 2026, alleging a chatbot persona named "Emilie" falsely claimed to be a licensed psychiatrist with a real medical license number, in a first-of-its-kind unlicensed-practice-of-medicine case against an AI companion platform.
UnitedHealth says its AI-driven PreCheck and OptumReal platforms now approve 96% of prior authorizations on first submission and cut missing-information denials by 68%, even as the AMA and multiple states push back on AI-driven claims denials.
OSF HealthCare has expanded its use of Rapid AI's stroke-detection software from its flagship hospitals to OSF St. Joseph Medical Center in Bloomington and rural hospitals across its Illinois network, letting neurologists review brain scans on their phones and speed up treatment decisions.
The FDA has cleared the Targeted Real-Time Early Warning System (TREWS), an AI tool born out of Johns Hopkins research and commercialized by Bayesian Health, marking the first authorized device that flags sepsis risk before clinicians even suspect it, with data showing an 18% cut in in-hospital mortality across dozens of U.S. hospitals.
Boston-based GenHealth.ai has raised a $16.5 million Series A led by Flare Capital Partners to expand its AI agents that automate prior authorization, billing, denials, and appeals for medical practices, bringing its total funding to $30 million.
Oura's integration with Counsel Health lets ring members chat with medical AI and escalate to a licensed physician inside the app, and on September 17, 2026 Counsel said it will extend AI-native chronic-care management to Medicare beneficiaries through the CMS ACCESS Model starting in early 2027.
Boston-based Elucid raised $55 million in an oversubscribed Series D, pushing total funding to roughly $185 million, to scale its FDA-cleared Plaque-IQ software and push its BioIntegrated FFR-CT tool through regulatory review.
A September 2026 review found fewer than a third of 903 FDA-authorized AI medical devices were validated on sex-specific populations, and as of this year developers can still win clearance without proving their tools perform equally for women.
A Colorado law that took effect August 12, 2026 bars licensed therapists from letting AI directly conduct sessions or generate treatment plans without review, and forbids any chatbot from posing as a licensed mental health professional.
James Park and Eric Friedman, who built and sold Fitbit, launched Luffu Link on August 25, 2026: a $249.99 screenless LTE band that tracks health and mood by voice and can summon help without a phone nearby, aimed squarely at family caregiving.